Integrative Multi-Omics to identify Therapeutic Targets for COPD
Chronic Obstructive Pulmonary Disease (COPD) is a common illness that affects millions of Canadians, yet there are no effective therapies to treat it. Genes play a role in COPD development, and our proposal aims at identifying those genes in lung tissue that cause the disease. The Providence Airway Centre is very committed at helping COPD patients in Canada and worldwide. The proposed studies with Drs. Maen Obeidat and Maxwell Libbrecht will use publicly available genetic datasets to enable us to identify disease genes and then develop potential new biomarker and therapeutic treatments for COPD.